Increased levels of eIF3f expression are found to compromise proliferation and promote apoptosis in cancer cells[29], of which this pro-apoptotic property of eIF3f is presumably dependent on its interplay with CDK11 and the mammalian target of rapamycin (mTOR)[28,48]. Here, EIF3F is linked to cancer.